EATG » News

Call for applications: Continuous Patient Education (CoPE) new call opens

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline is 11…

The EATG publishes its position paper on sex work policy

Today, on the occasion of the International Day to End Violence Against Sex Workers, the European AIDS Treatment Group publishes its stand on the sex work policy debate and approaches…

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

The European AIDS Treatment Group supports the petition towards the next Global Fund Replenishment Conference

Ahead of the next conference to replenish the Global Fund in October 2019 in France, AIDES -together with collaborating organisations (Action Santé Mondiale / Global Health Advocates, Coalition PLUS, Équilibres & Populations, Médecins du…

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

HIV Outcomes: Online Compendium of Good Practices for the long-term health of people living with HIV launched

BRUSSELS: Today, HIV Outcomes launched an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.   Although people with HIV can now anticipate…

EmERGE: Community Meeting for the Last Phase of the Project (Madrid – November 7 2018)

The EmERGE project (about developing a mHealth platform for self-management of HIV and reducing face-to-face consultations), funded by the European Commission, has started its last 18 months. The European AIDS…

14 Patient Organisations Call for Meaningful Involvement in European Cooperation on Health Technology Assessment (HTA)

Today, 14 European patient organisations & federations have launched a statement calling on European institutions to adopt appropriate measures to fully incorporate meaningful involvement of patients in EU cooperation on…

The EATG publishes its position paper on drugs policy

Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…

The EATG in the Civil Society Fora joint meetings (Brussels 6-8 November)

From 6-8 November, the EATG will be actively engaged in developing joint advocacy, sharing with and learning from civil society partners across Europe within the EU Civil Society Forum  on…

HIV Drug Therapy 2018 Congress – Quality of Life Across Different Age Groups of People Living with HIV: A Community Perspective

The European AIDS Treatment Group had the opportunity to co-organise and co-chair the ‘Quality of Life Across Different Age Groups of PLHIV: A Community Perspective’ session during this year's HIV Drug Therapy…

STEPS V: HIV CURE COMMUNITY WORKSHOP IN GLASGOW

STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held…

HIV Outcomes meeting: Improving long-term health and well-being of people living with HIV (Brussels – 27 November 2018)

One year after the launch of policy recommendations in the European Parliament, the HIV Outcomes initiative returns with an event to launch a "virtual good practice clinic" on chronic HIV…

Join the EATG at the 2018 HIV Drug Therapy Congress in Glasgow

The European AIDS Treatment Group is present at the 2018 HIV Drug Therapy Congress in Glasgow, from the 28th to the 31st of October. As with the previous versions of…

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living with HIV/AIDS, was recently updated. This is a joint collaboration…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together with the report we are also launching a set of video…

The EU Civil Society Forum on HIV/AIDS, TB and viral hepatitis reacts to the relevant Commission Staff Working Document

GASTEIN - On 4 October -on the occasion of the European Health Forum discussion on Reaching the SDG targets on Health by 2030 - Actions needed to end AIDS & TB…

#JusticeForZak: sign the petition, join the campaign

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. We call all relevant Greek authorities for a swift, thorough, independent and impartial investigation into…

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open…

Efavirenz in pregnancy is at least as safe as other antiretrovirals

No safety signal for raltegravir either An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure…

ECDC: Hepatitis A – Annual epidemiological report for 2016

The European Centre for Disease Prevention and Control (ECDC) released the Hepatitis A – Annual epidemiological report for 2016. The report can be downloaded here.  

Hepatitis goes undiagnosed in cancer patients

Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show that an alarmingly high rate of undiagnosed acute and chronic hepatitis B…

New blood tests for TB could accelerate diagnosis and save the NHS England money

Rapid blood tests used by the National Health Service (NHS) in England are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 348 of the ‘Global Fund Observer.’ The newsletter includes articles…

UNAIDS, UNICEF and WHO urge countries in western and central Africa to step up the pace in the response to HIV for children and adolescents

DAKAR/GENEVA, 16 January 2019—At a high-level meeting in Dakar, Senegal, UNAIDS, the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) urged countries in western and central Africa…

HIV control criteria: overview & expert roundtable

Although the overall number of new HIV infections has declined worldwide, it is estimated that 5000 new infections occur each day.1 With continuing progress in the implementation of treatment and prevention…

African women prefer multipurpose HIV prevention products

Researchers borrow from behavioural economics to understand what women in sub-Saharan Africa really want from a pre-exposure prophylaxis (PrEP) product. Young women in South Africa and Kenya would prefer injectable HIV prevention…

Half of Malaysian doctors admit to some discrimination against patients with HIV

Just over half of physicians at two of Malaysia’s leading medical universities expressed some intention to discriminate against patients with HIV in a survey. Dr. Tee Ying Chew of the…

Success with DAA for hepatitis C prior to stem cell transplant

The results of 2 reported case studies of children with chronic hepatitis C infection indicated that viral eradication can be achieved and maintained until full immune recovery throughout allogeneic hematopoietic…

Barriers to HCV treatment access from the drug user’s point of view: stigma, complex lives and damaged veins

Despite access to hepatitis C treatment treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the attitudes of healthcare workers, the difficulty of juggling treatment…

Egypt proposes plan to treat African hepatitis C patients

CAIRO - 16 January 2019: Minister of Health Hala Zayed unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries who have an…

HepVu releases state-level maps showing impact of hepatitis C epidemic across the U.S.

New data from Emory, UAlbany, and CDC show nine states make up more than 50 percent of hepatitis C infections ATLANTA, Jan. 16, 2019 – Today, HepVu launched new interactive maps visualizing state-level…

A call to action for effective responses to problematic chemsex

A position paper from organisers and participants of the 2nd European Chemsex Forum 22-24 March 2018, Berlin, Germany The position paper is based on discussions at the 2nd European Chemsex…

Back to the future with CD4 testing: improving HIV care in low- and middle-income countries

A practical resource-based public health approach for the rapid initiation of antiretroviral therapy in HIV-infected individuals living in low- and middle-income countries could save thousands of lives, according to an…

HIV and schistosomiasis programmes should be combined to reduce the spread of HIV

Testing and treatment programmes for HIV and schistosomiasis (also known as snail fever or bilharzia) could be profitably combined in settings with a high prevalence of both infections, results of…

UNAIDS calls for a fully funded Global Fund to Fight AIDS, Tuberculosis and Malaria

GENEVA, 14 January 2019—As the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) launches its sixth replenishment for its next three-year funding cycle, UNAIDS is urging donors to…

European Laboratory Initiative on TB expands to cover HIV and viral hepatitis

To strengthen and streamline the joint response to tuberculosis (TB), HIV and viral hepatitis in the WHO European Region, the WHO-established European Laboratory Initiative on TB extended its scope to…

Family duty is a powerful force in China. Is that why so many couples signed up for the ‘CRISPR babies’ experiment?

BEIJING — It’s been more than four years since the university student walked into an HIV testing center where Cui Zixiao worked, but he still vividly remembers what happened next.…